mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach

The U.S. Food and Drug Administration (FDA) has recently issued an Emergency Use Authorization (EUA) for 2 highly effective coronavirus disease 2019 (COVID-19) vaccines from Pfizer-BioNTech and Moderna. This has brought hope to millions of Americans in the midst of an ongoing global pandemic. The FD...

Descripción completa

Detalles Bibliográficos
Autores principales: Banerji, Aleena, Wickner, Paige G., Saff, Rebecca, Stone, Cosby A., Robinson, Lacey B., Long, Aidan A., Wolfson, Anna R., Williams, Paul, Khan, David A., Phillips, Elizabeth, Blumenthal, Kimberly G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Academy of Allergy, Asthma & Immunology 2021
Materias:
Review and Feature Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948517/
https://www.ncbi.nlm.nih.gov/pubmed/33388478
http://dx.doi.org/10.1016/j.jaip.2020.12.047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948517/
https://www.ncbi.nlm.nih.gov/pubmed/33388478
http://dx.doi.org/10.1016/j.jaip.2020.12.047

Ejemplares similares